Faizal Hussein, DR | |
3244 31st Street, Queens, NY 11106 | |
(718) 626-2699 | |
Not Available |
Full Name | Faizal Hussein |
---|---|
Gender | Male |
Speciality | Physical Therapy |
Experience | 4 Years |
Location | 3244 31st Street, Queens, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700492303 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 046330 (New York) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Professional Occupational And Physical Therapy Pllc | 3779873401 | 518 |
Ivyrehab Physical Therapy Pllc | 7012997638 | 276 |
News Archive
Scientists might have found an early detection method for some forms of dementia, according to new research by the University of Arizona and the University of Toronto's Baycrest Health Sciences Centre.
Fewer than 100 people in the world are known to be affected by a movement disorder called rapid-onset dystonia-parkinsonism (RDP), but its symptoms are life-changing. Seemingly normal young people are suddenly and dramatically unable to control movement of their arms or legs and have trouble speaking or swallowing. A normal life is nearly impossible.
BioLineRx, a biopharmaceutical development company, announced today that it has received all necessary regulatory approvals in the US to commence a Phase IIa trial for BL-8040, for the treatment of Acute Myeloid Leukemia.
Researchers aimed to find a relationship between geographic variation in Medicare Part D spending and medication-taking behavior among patients with diabetes or heart failure.
› Verified 9 days ago
Provider Name | Ivyrehab Physical Therapy Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1396799409 PECOS PAC ID: 7012997638 Enrollment ID: O20040723000705 |
News Archive
Scientists might have found an early detection method for some forms of dementia, according to new research by the University of Arizona and the University of Toronto's Baycrest Health Sciences Centre.
Fewer than 100 people in the world are known to be affected by a movement disorder called rapid-onset dystonia-parkinsonism (RDP), but its symptoms are life-changing. Seemingly normal young people are suddenly and dramatically unable to control movement of their arms or legs and have trouble speaking or swallowing. A normal life is nearly impossible.
BioLineRx, a biopharmaceutical development company, announced today that it has received all necessary regulatory approvals in the US to commence a Phase IIa trial for BL-8040, for the treatment of Acute Myeloid Leukemia.
Researchers aimed to find a relationship between geographic variation in Medicare Part D spending and medication-taking behavior among patients with diabetes or heart failure.
› Verified 9 days ago
Provider Name | In-motion Physical Therapy Pc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1578631727 PECOS PAC ID: 1254421282 Enrollment ID: O20071214000242 |
News Archive
Scientists might have found an early detection method for some forms of dementia, according to new research by the University of Arizona and the University of Toronto's Baycrest Health Sciences Centre.
Fewer than 100 people in the world are known to be affected by a movement disorder called rapid-onset dystonia-parkinsonism (RDP), but its symptoms are life-changing. Seemingly normal young people are suddenly and dramatically unable to control movement of their arms or legs and have trouble speaking or swallowing. A normal life is nearly impossible.
BioLineRx, a biopharmaceutical development company, announced today that it has received all necessary regulatory approvals in the US to commence a Phase IIa trial for BL-8040, for the treatment of Acute Myeloid Leukemia.
Researchers aimed to find a relationship between geographic variation in Medicare Part D spending and medication-taking behavior among patients with diabetes or heart failure.
› Verified 9 days ago
Provider Name | Physiocare Physical Therapy Pc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1366600793 PECOS PAC ID: 6204993538 Enrollment ID: O20090331000532 |
News Archive
Scientists might have found an early detection method for some forms of dementia, according to new research by the University of Arizona and the University of Toronto's Baycrest Health Sciences Centre.
Fewer than 100 people in the world are known to be affected by a movement disorder called rapid-onset dystonia-parkinsonism (RDP), but its symptoms are life-changing. Seemingly normal young people are suddenly and dramatically unable to control movement of their arms or legs and have trouble speaking or swallowing. A normal life is nearly impossible.
BioLineRx, a biopharmaceutical development company, announced today that it has received all necessary regulatory approvals in the US to commence a Phase IIa trial for BL-8040, for the treatment of Acute Myeloid Leukemia.
Researchers aimed to find a relationship between geographic variation in Medicare Part D spending and medication-taking behavior among patients with diabetes or heart failure.
› Verified 9 days ago
Provider Name | Professional Occupational & Physical Therapy Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1205296902 PECOS PAC ID: 3779873401 Enrollment ID: O20160608000715 |
News Archive
Scientists might have found an early detection method for some forms of dementia, according to new research by the University of Arizona and the University of Toronto's Baycrest Health Sciences Centre.
Fewer than 100 people in the world are known to be affected by a movement disorder called rapid-onset dystonia-parkinsonism (RDP), but its symptoms are life-changing. Seemingly normal young people are suddenly and dramatically unable to control movement of their arms or legs and have trouble speaking or swallowing. A normal life is nearly impossible.
BioLineRx, a biopharmaceutical development company, announced today that it has received all necessary regulatory approvals in the US to commence a Phase IIa trial for BL-8040, for the treatment of Acute Myeloid Leukemia.
Researchers aimed to find a relationship between geographic variation in Medicare Part D spending and medication-taking behavior among patients with diabetes or heart failure.
› Verified 9 days ago
Provider Name | Lake Success Physical Therapy Pc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1336604222 PECOS PAC ID: 8123366291 Enrollment ID: O20190214002919 |
News Archive
Scientists might have found an early detection method for some forms of dementia, according to new research by the University of Arizona and the University of Toronto's Baycrest Health Sciences Centre.
Fewer than 100 people in the world are known to be affected by a movement disorder called rapid-onset dystonia-parkinsonism (RDP), but its symptoms are life-changing. Seemingly normal young people are suddenly and dramatically unable to control movement of their arms or legs and have trouble speaking or swallowing. A normal life is nearly impossible.
BioLineRx, a biopharmaceutical development company, announced today that it has received all necessary regulatory approvals in the US to commence a Phase IIa trial for BL-8040, for the treatment of Acute Myeloid Leukemia.
Researchers aimed to find a relationship between geographic variation in Medicare Part D spending and medication-taking behavior among patients with diabetes or heart failure.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Faizal Hussein, DR 110-16 72 Ave Apt. 202, Forest Hills, NY 11375 Ph: () - | Faizal Hussein, DR 3244 31st Street, Queens, NY 11106 Ph: (718) 626-2699 |
News Archive
Scientists might have found an early detection method for some forms of dementia, according to new research by the University of Arizona and the University of Toronto's Baycrest Health Sciences Centre.
Fewer than 100 people in the world are known to be affected by a movement disorder called rapid-onset dystonia-parkinsonism (RDP), but its symptoms are life-changing. Seemingly normal young people are suddenly and dramatically unable to control movement of their arms or legs and have trouble speaking or swallowing. A normal life is nearly impossible.
BioLineRx, a biopharmaceutical development company, announced today that it has received all necessary regulatory approvals in the US to commence a Phase IIa trial for BL-8040, for the treatment of Acute Myeloid Leukemia.
Researchers aimed to find a relationship between geographic variation in Medicare Part D spending and medication-taking behavior among patients with diabetes or heart failure.
› Verified 9 days ago
Albaraa Hendawi, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 23-31 Steinway St, Queens, NY 11103 Phone: 929-463-7104 | |
Mrs. Elizabeth Tortorello, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 155-02 108th Ave, Queens, NY 11433 Phone: 718-556-6731 | |
Ehab Abdelmesseh Armanious, Physical Therapist Medicare: Medicare Enrolled Practice Location: 5910 Junction Blvd Elmhurst, Queens, NY 11373 Phone: 718-255-6999 | |
Bridget Krumholz, Physical Therapist Medicare: Medicare Enrolled Practice Location: 270-05 76th Ave, Queens, NY 11040 Phone: 718-470-7000 | |
Miss Sneha Satheesh Menon, P.T., M.S. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 265 Beach 20th Street Far Rockaway, Queens, NY 11691 Phone: 718-337-7877 | |
Kia Nichole Antipuesto, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 140-40 Sanford Avenue, Queens, NY 11355 Phone: 718-353-1400 | |
Ramchandr Singh Kundan, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10946 Vanwyck Expressway, #1, Queens, NY 11420 Phone: 718-323-2933 Fax: 718-323-2931 |